Strategic Advisors LLC Teva Pharmaceutical Industries LTD Transaction History

Strategic Advisors LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2019 Jul 22, 2019	SELL	$8.12 - $15.72 $125,453 - $242,874	-15,450 Closed	0 $0
Q1 2019 Apr 15, 2019	SELL	$15.58 - $20.01 $31,160 - $40,020	-2,000 Reduced 11.46%	15,450 $242,000
Q4 2018 Jan 24, 2019	SELL	$14.59 - $23.84 $58,360 - $95,360	-4,000 Reduced 18.65%	17,450 $269,000
Q3 2018 Oct 18, 2018	SELL	$21.06 - $25.65 $42,120 - $51,300	-2,000 Reduced 8.53%	21,450 $462,000
Q2 2018 Jul 30, 2018	BUY	$16.77 - $24.71 $393,256 - $579,449	23,450 New	23,450 $570,000

625

573M

19.6M

6.77M

Ticker TEVA
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 1,110,560,000
Market Cap $25.3B
Description
Teva Pharmaceutical Industries Limited, a pharmaceutical company, develops, manufactures, markets, and distributes generic medicines, specialty medicines, and biopharmaceutical products in North America, Europe, and internationally. The company offers sterile products, hormones, high-potency drugs, and cytotoxic substances in various dosage form...

Get notified when there are updates to the investment portfolio of Strategic Advisors LLC, based on Form 13F filings with the SEC.

Stay updated on Strategic Advisors LLC with notifications on news.